Harnessing small extracellular vesicles for pro-oxidant delivery: novel approach for drug-sensitive and resistant cancer therapy C Kang, X Ren, D Lee, R Ramesh, S Nimmo, Y Yang-Hartwich, D Kim Journal of Controlled Release 365, 286-300, 2024 | 2 | 2024 |
Differential responses to double-stranded RNA injection and feeding in Mormon cricket (Orthoptera: Tettigoniidae) S Rana, C Kang, J Allred, JH Medina-Duran, A Canova, D Sherry, ... Journal of Insect Science 23 (4), 10, 2023 | | 2023 |
Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications X Ren, C Kang, L Garcia-Contreras, D Kim International Journal of Molecular Sciences 24 (9), 8166, 2023 | | 2023 |
Intraocular RGD-engineered exosomes and active targeting of choroidal neovascularization (CNV) D Pollalis, D Kim, GKG Nair, C Kang, AV Nanda, SY Lee Cells 11 (16), 2573, 2022 | 15 | 2022 |
Exosome based anti-VEGF drug delivery combined with active targeting of choroidal neovascularization (CNV) SY Lee, D Pollalis, GKG Nair, A Nanda, C Kang, D Kim Investigative Ophthalmology & Visual Science 63 (7), 1331–F0165-1331–F0165, 2022 | | 2022 |
Exosome delivery to retina and active targeting of CNV by RGD-conjugated exosomes D Pollalis, GKG Nair, AV Nanda, C Kang, D Kim, SY Lee Investigative Ophthalmology & Visual Science 63 (7), 303–F0106-303–F0106, 2022 | 1 | 2022 |
A kidney-targeted nanoparticle to augment renal lymphatic density decreases blood pressure in hypertensive mice BL Goodlett, CS Kang, E Yoo, S Navaneethabalakrishnan, ... Pharmaceutics 14 (1), 84, 2021 | 8 | 2021 |
H2O2-responsive antioxidant nanoparticle attenuates whole body ischemia/reperfusion-induced multi-organ damages R Li, SJ Rhee, S Bae, S Su, CS Kang, Q Ke, YE Koo, C Ryu, CG Song, ... Journal of Cardiovascular Pharmacology and Therapeutics 26 (3), 279-288, 2021 | 7 | 2021 |
Anchor, spacer, and ligand-modified engineered exosomes for trackable targeted therapy C Kang, P Han, JS Lee, D Lee, D Kim Bioconjugate Chemistry 31 (11), 2541-2552, 2020 | 25 | 2020 |
A Kidney-Targeted Nanoparticle To Augment Renal Lymphatic Density Decreases Blood Pressure In Mice With L-NAME-And Angiotensin II-Induced Hypertension BL Goodlett, E Yoo, CS Kang, D Balasubbramanian, S Love, W Tate, ... HYPERTENSION 76, 2020 | | 2020 |
Abstract P132: A Kidney-Targeted Nanoparticle To Augment Renal Lymphatic Density Decreases Blood Pressure In Mice With L-NAME-And Angiotensin II-Induced Hypertension BL Goodlett, E Yoo, CS Kang, D Balasubbramanian, S Love, W Tate, ... Hypertension 76 (Suppl_1), AP132-AP132, 2020 | | 2020 |
Nanoconfinement-mediated cancer theranostics C Kang, D Kim Archives of pharmacal research 43 (1), 110-117, 2020 | 9 | 2020 |
Acid-activatable polymeric curcumin nanoparticles as therapeutic agents for osteoarthritis C Kang, E Jung, H Hyeon, S Seon, D Lee Nanomedicine: Nanotechnology, Biology and Medicine 23, 102104, 2020 | 90 | 2020 |
Hydrogen peroxide-activatable polymeric prodrug of curcumin for ultrasound imaging and therapy of acute liver failure SVB Singh, E Jung, J Noh, D Yoo, C Kang, H Hyeon, GW Kim, G Khang, ... Nanomedicine: Nanotechnology, Biology and Medicine 16, 45-55, 2019 | 27 | 2019 |
Dual Imaging-Guided Oxidative–Photothermal Combination Anticancer Therapeutics J Noh, E Jung, D Yoo, C Kang, C Kim, S Park, G Khang, D Lee ACS applied materials & interfaces 10 (47), 40424-40433, 2018 | 12 | 2018 |
Ultrasound imaging and on-demand therapy of peripheral arterial diseases using H2O2-Activated bubble generating anti-inflammatory polymer particles E Jung, J Noh, C Kang, D Yoo, C Song, D Lee Biomaterials 179, 175-185, 2018 | 48 | 2018 |
Molecularly Engineered Theranostic Nanoparticles for Thrombosed Vessels: H2O2-Activatable Contrast-Enhanced Photoacoustic Imaging and Antithrombotic … E Jung, C Kang, J Lee, D Yoo, DW Hwang, D Kim, SC Park, SK Lim, ... Acs Nano 12 (1), 392-401, 2018 | 108 | 2018 |
Fibrin-Targeted and H2O2-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels C Kang, S Gwon, CG Song, PM Kang, SC Park, J Jeon, DW Hwang, ... Acs Nano 11 (6), 6194-6203, 2017 | 113 | 2017 |
Dual stimuli-activatable oxidative stress amplifying agent as a hybrid anticancer prodrug E Han, B Kwon, D Yoo, C Kang, G Khang, D Lee Bioconjugate Chemistry 28 (4), 968-978, 2017 | 31 | 2017 |
Hydrogen peroxide-activatable nanotherapeutics: Ultrasound imaging and anti-inflammatory therapy of oxidative stress-associated diseases D Lee, C Kang, E Jung, E Hong, Y Go ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |